Featured Research

from universities, journals, and other organizations

Blood Pressure Drug May Help Stall Parkinson's

Date:
June 15, 2007
Source:
Rosalind Franklin University of Medicine and Science
Summary:
Northwestern University researchers are studying the drug isradipine and its effects on Parkinson's disease, including a chronic mouse model that mimics the signs and symptoms of Parkinson's disease. The scientists are collaborating to see if the drug could stop cells from dying in the mouse model. Findings indicated that isradipine slowed the disease process and destruction of the dopamine-producing neurons.

Gloria E. Meredith, Ph.D., collaborated with D. James Surmeier, Ph.D. and other scientists at Northwestern University to study the drug, isradipine, and its possible effects on Parkinson's disease. The findings of this study were published this week in an article in Nature.

Dr. Meredith, Professor and Chair of the Department of Cellular and Molecular Pharmacology at Rosalind Franklin University of Medicine and Science, and an expert in Parkinson's disease, co-authored the article. She commented, "Parkinson's disease is a motor disorder caused by the death of dopamine-producing nerve cells in our brains. There is a big race to protect these neurons from dying. Currently available drugs only treat the symptoms."

Dr. Meredith, who studies a chronic mouse model that mimics the signs and symptoms of Parkinson's disease, said, "Isradipine is a common drug used to treat hypertension and stroke. Dr. Surmeier had developed the idea that this drug, a calcium channel blocker, may help protect dopamine neurons in humans. He also designed the basic study. We joined together to see if the drug could stop cells from dying in the mouse model. Our findings indicated that isradipine slowed the disease process and destruction of the dopamine-producing neurons. Results from the mouse model indicate that if the drug works in humans, then it could be used as a means to prevent the onset of this disease or slow its progression."

The next phase will be to develop clinical trials in humans. Dr. Meredith said, "It's exciting to think that if we can protect the dopamine neurons from dying, we may prevent the disease, and improve the quality of life for patients."

Dr. Meredith has been studying Parkinson's disease for over 15 years. Her research is currently funded by the National Institute of Neurological Disorders and Stroke (NINDS), a division of the National Institutes of Health (NIH), and the Department of Defense.


Story Source:

The above story is based on materials provided by Rosalind Franklin University of Medicine and Science. Note: Materials may be edited for content and length.


Cite This Page:

Rosalind Franklin University of Medicine and Science. "Blood Pressure Drug May Help Stall Parkinson's." ScienceDaily. ScienceDaily, 15 June 2007. <www.sciencedaily.com/releases/2007/06/070613131846.htm>.
Rosalind Franklin University of Medicine and Science. (2007, June 15). Blood Pressure Drug May Help Stall Parkinson's. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2007/06/070613131846.htm
Rosalind Franklin University of Medicine and Science. "Blood Pressure Drug May Help Stall Parkinson's." ScienceDaily. www.sciencedaily.com/releases/2007/06/070613131846.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com
FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins